BioRestorative Therapies Appoints David Jenkins to Board, Names Committee Chairs
BioRestorative Therapies, Inc. announced significant changes to its Board of Directors. Esha Randhawa and Jatinder Dhaliwal have resigned from their positions. To fill the vacancy, David Jenkins was appointed as a Class III director and will serve until the 2026 annual meeting. Mr. Jenkins has also been appointed as Chair of the Compensation Committee and the Nominating and Corporate Governance Committee, and as a member of the Audit Committee. Donald J. Currie was also appointed to the Audit Committee. The company has fixed the number of directors at four.
Key Highlights
- Esha Randhawa resigned from the Board of Directors on November 5, 2026.
- Jatinder Dhaliwal resigned from the Board of Directors on November 6, 2026.
- David Jenkins appointed as a Class III director on November 10, 2026.
- David Jenkins appointed Chair of the Compensation Committee and Nominating and Corporate Governance Committee.
- Donald J. Currie appointed as a member of the Audit Committee.
- David Jenkins to receive CAD $2,000 per month as compensation.
- David Jenkins determined to be an independent director and audit committee financial expert.
Price Impact
More from BRTX
BioRestorative Therapies CEO, CFO Resign Amid Severance Dispute
BioRestorative completes BRTX-100 Phase 2 clinical trial manufacturing
BioRestorative Therapies Appoints Zachary Smith as VP of Biocosmeceuticals